ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
13.55
-0.24 (-1.74%)
At close: Nov 20, 2024, 4:00 PM
13.35
-0.20 (-1.48%)
After-hours: Nov 20, 2024, 5:14 PM EST
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $1.32 billion as of November 21, 2024. Its market cap has increased by 284.90% in one year.
Market Cap
1.32B
Enterprise Value
1.11B
1-Year Change
284.90%
Ranking
Category
Stock Price
$13.55
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $1.32B, an increase of 131.74%. That is a compound annual growth rate of 51.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 1.34B | 154.76% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| U.S. Physical Therapy | 1.36B |
| Harrow | 1.35B |
| Cassava Sciences | 1.34B |
| MiMedx Group | 1.34B |
| Praxis Precision Medicines | 1.33B |
| Schrödinger | 1.33B |
| Arcus Biosciences | 1.32B |
| Day One Biopharmaceuticals | 1.31B |